mHealth Apps Market (By Product: Medical Apps, Fitness Apps) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20222030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global MHealth Apps Market, By Product Type

7.1.  MHealth Apps Market, by Product Type, 2021-2030

7.1.1.    Medical Apps

7.1.1.1.        Market Revenue and Forecast (2019-2030)

7.1.2.    Fitness Apps

7.1.2.1.        Market Revenue and Forecast (2019-2030)

Chapter 8.  Global MHealth Apps Market, Regional Estimates and Trend Forecast

8.1.  North America

8.1.1.    Market Revenue and Forecast, by Product Type (2019-2030)

8.1.2.    U.S.

8.1.3.    Rest of North America

8.1.3.1.        Market Revenue and Forecast, by Product Type (2019-2030)

8.2.  Europe

8.2.1.    Market Revenue and Forecast, by Product Type (2019-2030)

8.2.2.    UK

8.2.2.1.        Market Revenue and Forecast, by Product Type (2019-2030)

8.2.3.    France

8.2.3.1.        Market Revenue and Forecast, by Product Type (2019-2030)

8.2.4.    Rest of Europe

8.2.4.1.        Market Revenue and Forecast, by Product Type (2019-2030)

8.3.  APAC

8.3.1.    Market Revenue and Forecast, by Product Type (2019-2030)

8.3.2.    India

8.3.2.1.        Market Revenue and Forecast, by Product Type (2019-2030)

8.3.3.    China

8.3.3.1.        Market Revenue and Forecast, by Product Type (2019-2030)

8.3.4.    Japan

8.3.4.1.        Market Revenue and Forecast, by Product Type (2019-2030)

8.3.5.    Rest of APAC

8.3.5.1.        Market Revenue and Forecast, by Product Type (2019-2030)

8.4.  MEA

8.4.1.    Market Revenue and Forecast, by Product Type (2019-2030)

8.4.2.    GCC

8.4.2.1.        Market Revenue and Forecast, by Product Type (2019-2030)

8.4.3.    North Africa

8.4.3.1.        Market Revenue and Forecast, by Product Type (2019-2030)

8.4.4.    South Africa

8.4.4.1.        Market Revenue and Forecast, by Product Type (2019-2030)

8.4.5.    Rest of MEA

8.4.5.1.        Market Revenue and Forecast, by Product Type (2019-2030)

8.5.  Latin America

8.5.1.    Market Revenue and Forecast, by Product Type (2019-2030)

8.5.2.    Brazil

8.5.2.1.        Market Revenue and Forecast, by Product Type (2019-2030)

8.5.3.    Rest of LATAM

8.5.3.1.        Market Revenue and Forecast, by Product Type (2019-2030)

Chapter 9.    Company Profiles

9.1.  Teladoc Health, Inc.

9.1.1.    Company Overview

9.1.2.    Product Offerings

9.1.3.    Financial Performance

9.1.4.    Recent Initiatives

9.2.  AstraZeneca PLC

9.2.1.    Company Overview

9.2.2.    Product Offerings

9.2.3.    Financial Performance

9.2.4.    Recent Initiatives

9.3.  Abbott Laboratories

9.3.1.    Company Overview

9.3.2.    Product Offerings

9.3.3.    Financial Performance

9.3.4.    Recent Initiatives

9.4.  Sanofi

9.4.1.    Company Overview

9.4.2.    Product Offerings

9.4.3.    Financial Performance

9.4.4.    Recent Initiatives

9.5.  Johnson and Johnson

9.5.1.    Company Overview

9.5.2.    Product Offerings

9.5.3.    Financial Performance

9.5.4.    Recent Initiatives

9.6.  Bristol-Myers Squibb Company

9.6.1.    Company Overview

9.6.2.    Product Offerings

9.6.3.    Financial Performance

9.6.4.    Recent Initiatives

9.7.  Novartis AG

9.7.1.    Company Overview

9.7.2.    Product Offerings

9.7.3.    Financial Performance

9.7.4.    Recent Initiatives

9.8.  F. Hoffmann-La Roche Ltd.

9.8.1.    Company Overview

9.8.2.    Product Offerings

9.8.3.    Financial Performance

9.8.4.    Recent Initiatives

Chapter 10.  Research Methodology

10.1.              Primary Research

10.2.              Secondary Research

10.3.              Assumptions

Chapter 11.  Appendix

11.1.              About Us

11.2.              Glossary of Terms